— Know what they know.
Not Investment Advice

9606.HK

Duality Biotherapeutics, Inc.
1W: -11.1% 1M: -22.4% 3M: -10.8% YTD: -20.6%
HK$256.00 ($32.74)
-7.20 (-2.74%)
 
HKSE · Healthcare · Biotechnology · HK$23.2B
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market CapHK$23.2B ($3.0B)
52W Range165.5-563.5
Volume781,235
Avg Volume736,438
Beta2.47
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOZhongyuan Zhu
Employees170
SectorHealthcare
IndustryBiotechnology
IPO Date2025-04-15
Units 1103-1106, Building A, 868 Yinghua Road
Shanghai 201204
CN
86 (21) 2601 8730
About Duality Biotherapeutics, Inc.

Duality Biotherapeutics, Inc. operates as a clinical stage company. It focuses on the development of next generation antibody-drug conjugate therapeutics and duality immune toxin antibody conjugate therapeutic. The company was founded by Zhu Zhong Yuan on July 3, 2019 and is headquartered in Shanghai, China.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms